NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

ATACseq: ATAC epigenome profiling Analytic Validation (Stanford)   Add to my SOP compendium

BRD ID: 3,104

Source: CIMAC-CIDC Network Tier: SOP Number of times downloaded: 10

Description

This assay analytical validation and performance report describes the methods used to validate the assay for transposase-accessible chromatin (ATAC) epigenome profiling using GM12878 cell line samples and presents data supporting the reported accuracy, inter- and intra-assay precision, analytical sensitivity and specificity, reference interval, and turnaround time. It is used by the Cancer Immune Monitoring and Analysis Center (CIMAC) at Stanford University. It is a product of the Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Center Network (CIMAC-CIDC Network; https://dctd.cancer.gov/ResearchNetworks/cimacs_cidc_network.htm), a Cancer Moonshot Initiative.

Documents for Download

Analytical report_ATACseq_2018_Stanford_508_Final.pdf [Size: 395 KB]

Biospecimens
  • Cell - Lymph Node
Diagnoses
  • Neoplastic - Lymphoma
Topics
  • Platform-specific Methodology

Associated SOP Compendiums

News and Announcements

  • Just Published!

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • More...